Compile Data Set for Download or QSAR
Report error Found 36 of affinity data for UniProtKB/TrEMBL: P59722
TargetEgl nine homolog 1(Rat)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM242558(US9422240, 1-353)
Affinity DataIC50: 18nMAssay Description:Inhibition of rat PHD2 using FITC-HIF1-alpha as substrate after 10 mins in presence of 2-oxoglutarate by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/1/2020
Entry Details Article
PubMed
TargetEgl nine homolog 1(Rat)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM123039(US8742138, 24)
Affinity DataIC50: 30nMT: 2°CAssay Description:HIF-PHD2 activity was measured using homogeneous TR-FRET technology (see also, US2008/004817; Dao J H et al., Anal Biochem. 2009, 384:213-23). To eac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2014
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Rat)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM123045(US8742138, 30)
Affinity DataIC50: 80nMT: 2°CAssay Description:HIF-PHD2 activity was measured using homogeneous TR-FRET technology (see also, US2008/004817; Dao J H et al., Anal Biochem. 2009, 384:213-23). To eac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2014
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Rat)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM123043(US8742138, 28)
Affinity DataIC50: 80nMT: 2°CAssay Description:HIF-PHD2 activity was measured using homogeneous TR-FRET technology (see also, US2008/004817; Dao J H et al., Anal Biochem. 2009, 384:213-23). To eac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2014
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Rat)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM123036(US8742138, 21)
Affinity DataIC50: 90nMT: 2°CAssay Description:HIF-PHD2 activity was measured using homogeneous TR-FRET technology (see also, US2008/004817; Dao J H et al., Anal Biochem. 2009, 384:213-23). To eac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2014
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Rat)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM123033(US8742138, 18)
Affinity DataIC50: 90nMT: 2°CAssay Description:HIF-PHD2 activity was measured using homogeneous TR-FRET technology (see also, US2008/004817; Dao J H et al., Anal Biochem. 2009, 384:213-23). To eac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2014
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Rat)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM123037(US8742138, 22)
Affinity DataIC50: 100nMT: 2°CAssay Description:HIF-PHD2 activity was measured using homogeneous TR-FRET technology (see also, US2008/004817; Dao J H et al., Anal Biochem. 2009, 384:213-23). To eac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2014
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Rat)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM123035(US8742138, 20)
Affinity DataIC50: 100nMT: 2°CAssay Description:HIF-PHD2 activity was measured using homogeneous TR-FRET technology (see also, US2008/004817; Dao J H et al., Anal Biochem. 2009, 384:213-23). To eac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2014
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Rat)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM123034(US8742138, 19)
Affinity DataIC50: 150nMT: 2°CAssay Description:HIF-PHD2 activity was measured using homogeneous TR-FRET technology (see also, US2008/004817; Dao J H et al., Anal Biochem. 2009, 384:213-23). To eac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2014
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Rat)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM123050(US8742138, 35)
Affinity DataIC50: 150nMT: 2°CAssay Description:HIF-PHD2 activity was measured using homogeneous TR-FRET technology (see also, US2008/004817; Dao J H et al., Anal Biochem. 2009, 384:213-23). To eac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2014
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Rat)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM123016(US8742138, 34 | US8742138, 1)
Affinity DataIC50: 150nMT: 2°CAssay Description:HIF-PHD2 activity was measured using homogeneous TR-FRET technology (see also, US2008/004817; Dao J H et al., Anal Biochem. 2009, 384:213-23). To eac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2014
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Rat)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM123044(US8742138, 29)
Affinity DataIC50: 150nMT: 2°CAssay Description:HIF-PHD2 activity was measured using homogeneous TR-FRET technology (see also, US2008/004817; Dao J H et al., Anal Biochem. 2009, 384:213-23). To eac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2014
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Rat)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM123042(US8742138, 27)
Affinity DataIC50: 150nMT: 2°CAssay Description:HIF-PHD2 activity was measured using homogeneous TR-FRET technology (see also, US2008/004817; Dao J H et al., Anal Biochem. 2009, 384:213-23). To eac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2014
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Rat)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM123041(US8742138, 26)
Affinity DataIC50: 150nMT: 2°CAssay Description:HIF-PHD2 activity was measured using homogeneous TR-FRET technology (see also, US2008/004817; Dao J H et al., Anal Biochem. 2009, 384:213-23). To eac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2014
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Rat)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM123040(US8742138, 25)
Affinity DataIC50: 150nMT: 2°CAssay Description:HIF-PHD2 activity was measured using homogeneous TR-FRET technology (see also, US2008/004817; Dao J H et al., Anal Biochem. 2009, 384:213-23). To eac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2014
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Rat)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM123038(US8742138, 23)
Affinity DataIC50: 150nMT: 2°CAssay Description:HIF-PHD2 activity was measured using homogeneous TR-FRET technology (see also, US2008/004817; Dao J H et al., Anal Biochem. 2009, 384:213-23). To eac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2014
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Rat)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM123023(US8742138, 8)
Affinity DataIC50: 150nMT: 2°CAssay Description:HIF-PHD2 activity was measured using homogeneous TR-FRET technology (see also, US2008/004817; Dao J H et al., Anal Biochem. 2009, 384:213-23). To eac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2014
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Rat)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM123017(US8742138, 2)
Affinity DataIC50: 150nMT: 2°CAssay Description:HIF-PHD2 activity was measured using homogeneous TR-FRET technology (see also, US2008/004817; Dao J H et al., Anal Biochem. 2009, 384:213-23). To eac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2014
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Rat)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM123018(US8742138, 3)
Affinity DataIC50: 150nMT: 2°CAssay Description:HIF-PHD2 activity was measured using homogeneous TR-FRET technology (see also, US2008/004817; Dao J H et al., Anal Biochem. 2009, 384:213-23). To eac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2014
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Rat)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM123019(US8742138, 4)
Affinity DataIC50: 150nMT: 2°CAssay Description:HIF-PHD2 activity was measured using homogeneous TR-FRET technology (see also, US2008/004817; Dao J H et al., Anal Biochem. 2009, 384:213-23). To eac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2014
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Rat)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM123020(US8742138, 5)
Affinity DataIC50: 150nMT: 2°CAssay Description:HIF-PHD2 activity was measured using homogeneous TR-FRET technology (see also, US2008/004817; Dao J H et al., Anal Biochem. 2009, 384:213-23). To eac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2014
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Rat)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM123021(US8742138, 6)
Affinity DataIC50: 150nMT: 2°CAssay Description:HIF-PHD2 activity was measured using homogeneous TR-FRET technology (see also, US2008/004817; Dao J H et al., Anal Biochem. 2009, 384:213-23). To eac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2014
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Rat)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM123022(US8742138, 7)
Affinity DataIC50: 150nMT: 2°CAssay Description:HIF-PHD2 activity was measured using homogeneous TR-FRET technology (see also, US2008/004817; Dao J H et al., Anal Biochem. 2009, 384:213-23). To eac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2014
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Rat)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM123024(US8742138, 9)
Affinity DataIC50: 150nMT: 2°CAssay Description:HIF-PHD2 activity was measured using homogeneous TR-FRET technology (see also, US2008/004817; Dao J H et al., Anal Biochem. 2009, 384:213-23). To eac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2014
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Rat)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM123025(US8742138, 10)
Affinity DataIC50: 150nMT: 2°CAssay Description:HIF-PHD2 activity was measured using homogeneous TR-FRET technology (see also, US2008/004817; Dao J H et al., Anal Biochem. 2009, 384:213-23). To eac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2014
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Rat)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM123026(US8742138, 11)
Affinity DataIC50: 150nMT: 2°CAssay Description:HIF-PHD2 activity was measured using homogeneous TR-FRET technology (see also, US2008/004817; Dao J H et al., Anal Biochem. 2009, 384:213-23). To eac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2014
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Rat)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM123027(US8742138, 12)
Affinity DataIC50: 150nMT: 2°CAssay Description:HIF-PHD2 activity was measured using homogeneous TR-FRET technology (see also, US2008/004817; Dao J H et al., Anal Biochem. 2009, 384:213-23). To eac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2014
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Rat)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM123028(US8742138, 13)
Affinity DataIC50: 150nMT: 2°CAssay Description:HIF-PHD2 activity was measured using homogeneous TR-FRET technology (see also, US2008/004817; Dao J H et al., Anal Biochem. 2009, 384:213-23). To eac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2014
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Rat)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM123030(US8742138, 15)
Affinity DataIC50: 150nMT: 2°CAssay Description:HIF-PHD2 activity was measured using homogeneous TR-FRET technology (see also, US2008/004817; Dao J H et al., Anal Biochem. 2009, 384:213-23). To eac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2014
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Rat)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM123032(US8742138, 17)
Affinity DataIC50: 200nMT: 2°CAssay Description:HIF-PHD2 activity was measured using homogeneous TR-FRET technology (see also, US2008/004817; Dao J H et al., Anal Biochem. 2009, 384:213-23). To eac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2014
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Rat)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM123048(US8742138, 33)
Affinity DataIC50: 200nMT: 2°CAssay Description:HIF-PHD2 activity was measured using homogeneous TR-FRET technology (see also, US2008/004817; Dao J H et al., Anal Biochem. 2009, 384:213-23). To eac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2014
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Rat)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM123016(US8742138, 34 | US8742138, 1)
Affinity DataIC50: 250nMT: 2°CAssay Description:HIF-PHD2 activity was measured using homogeneous TR-FRET technology (see also, US2008/004817; Dao J H et al., Anal Biochem. 2009, 384:213-23). To eac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2014
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Rat)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM123029(US8742138, 14)
Affinity DataIC50: 300nMT: 2°CAssay Description:HIF-PHD2 activity was measured using homogeneous TR-FRET technology (see also, US2008/004817; Dao J H et al., Anal Biochem. 2009, 384:213-23). To eac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2014
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Rat)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM123051(US8742138, 36)
Affinity DataIC50: 300nMT: 2°CAssay Description:HIF-PHD2 activity was measured using homogeneous TR-FRET technology (see also, US2008/004817; Dao J H et al., Anal Biochem. 2009, 384:213-23). To eac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2014
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Rat)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM123031(US8742138, 16)
Affinity DataIC50: 350nMT: 2°CAssay Description:HIF-PHD2 activity was measured using homogeneous TR-FRET technology (see also, US2008/004817; Dao J H et al., Anal Biochem. 2009, 384:213-23). To eac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2014
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Rat)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM123009(US8742138, 37 | US8742158, EX 21)
Affinity DataIC50: 700nMT: 2°CAssay Description:HIF-PHD2 activity was measured using homogeneous TR-FRET technology (see also, US2008/004817; Dao J H et al., Anal Biochem. 2009, 384:213-23). To eac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2014
Entry Details
Go to US Patent